Retatrutide is an advanced, investigational peptide that has emerged as a promising candidate for weight management and metabolic health research. Supplied in sterile vials at dosages of 5mg, 10mg, and 20mg, this pharmaceutical‑grade peptide is designed for precise subcutaneous administration, offering efficient bioavailability and rapid systemic uptake.
Retatrutide functions as a multi‑agonist, targeting several key receptors involved in appetite regulation, glucose homeostasis, and energy expenditure. By activating these pathways, Retatrutide helps to suppress hunger signals, enhance satiety, and promote the mobilization of stored fat. In preclinical studies, Retatrutide has demonstrated the ability to reduce body weight, improve insulin sensitivity, and support healthy lipid profiles without significant adverse effects.
| Product Name | Retatrutide Peptide |
| Shelf Life | 2 Years |
| Form | Peptide |
| Indication | Weight Loss |
| Dosage | 1mg~12mg/week |
| Active Ingredient | Retatrutide |
| Storage Conditions | Store At 2-25°C |
| Packaging | 10mg/vial, 15mg/vial, 20mg/vial, 30mg/vial, 40mg/vial |
Research in anti-obesity drugs and therapies.
Development of weight loss injections.
Study of diabetes and insulin resistance.
Use in fitness and bodybuilding for metabolic enhancement.
R&D in metabolic disorders and endocrinology.
For high value products, please select air shipping and express delivery for safety.
